Topical Application of Imiquimod as a Treatment for Chromoblastomycosis
| dc.contributor.author | Sousa, Maria Da Gloria | |
| dc.contributor.author | Belda Junior, Walter | |
| dc.contributor.author | Spina, Ricardo | |
| dc.contributor.author | Lota, Priscila Ramos | |
| dc.contributor.author | Valente, Neusa Sakai | |
| dc.contributor.author | Brown, Gordon D. | |
| dc.contributor.author | Criado, Paulo Ricardo | |
| dc.contributor.author | Benard, Gil | |
| dc.contributor.institution | University of Aberdeen.Applied Medicine | en |
| dc.date.accessioned | 2014-10-22T08:29:01Z | |
| dc.date.available | 2014-10-22T08:29:01Z | |
| dc.date.issued | 2014-06-15 | |
| dc.description.status | Peer reviewed | en |
| dc.format.extent | 4 | |
| dc.format.extent | 302772 | |
| dc.identifier | 40104989 | |
| dc.identifier | 68ce1132-43d1-44ce-9c17-f05edfa91d50 | |
| dc.identifier | 84901753820 | |
| dc.identifier.citation | Sousa, M D G, Belda Junior, W, Spina, R, Lota, P R, Valente, N S, Brown, G D, Criado, P R & Benard, G 2014, 'Topical Application of Imiquimod as a Treatment for Chromoblastomycosis', Clinical Infectious Diseases, vol. 58, no. 12, pp. 1734-1737. https://doi.org/10.1093/cid/ciu168 | en |
| dc.identifier.doi | 10.1093/cid/ciu168 | |
| dc.identifier.iss | 12 | en |
| dc.identifier.issn | 1058-4838 | |
| dc.identifier.uri | http://hdl.handle.net/2164/3741 | |
| dc.identifier.vol | 58 | en |
| dc.language.iso | eng | |
| dc.relation.ispartof | Clinical Infectious Diseases | en |
| dc.subject | imiquimod | en |
| dc.subject | chromoblastomycosis | en |
| dc.subject | Fonsecaea pedrosoi | en |
| dc.subject | innate immunity | en |
| dc.subject | antifungal treatment | en |
| dc.subject | QR Microbiology | en |
| dc.subject | Wellcome Trust | en |
| dc.subject | 92976 | en |
| dc.subject.lcc | QR | en |
| dc.title | Topical Application of Imiquimod as a Treatment for Chromoblastomycosis | en |
| dc.type | Journal article | en |